On Saturday, October 24, participants from across the nation will join together to show our united, unwavering commitment to the Foundation Fighting Blindness’ mission: to find treatments and cures for blinding retinal diseases. Even though we can’t physically be together, we can each find our own way to show our support.
Selected Filter
Displaying 211–211 of 211 research results
The study is designed to evaluate the pharmacodynamics, safety and tolerability of emixustat in subjects with macular atrophy secondary to Stargardt disease.
